{"entity":{"type":"insider","cik":"0001643921","url":"/insider/0001643921","json_url":"/insider/0001643921.json","name":"Bhatia Sangeeta N.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":63,"n_filings":27,"first":"2017-06-05","last":"2026-05-05","span_basis":"filed_date"},"name_variants":[{"name":"Bhatia Sangeeta N.","source":"filing","n_filings":27,"first_seen":"2017-06-05","last_seen":"2026-05-05"}],"transactions":[{"id":6104003,"accession":"0000875320-26-000175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000175","line_url":"/filing/0000875320-26-000175#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318.0,"shares_display":"318","price_per_share":423.73,"price_display":"423.73","price_state":"stated","total_value":134746.14,"total_display":"134,746.14","shares_owned_after":4924.0,"shares_owned_after_display":"4,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-05","scope":"insider"},{"id":5868412,"accession":"0000875320-26-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000062","line_url":"/filing/0000875320-26-000062#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":266.0,"shares_display":"266","price_per_share":500.0,"price_display":"500.00","price_state":"stated","total_value":133000.0,"total_display":"133,000.00","shares_owned_after":4299.0,"shares_owned_after_display":"4,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-18","scope":"insider"},{"id":4126158,"accession":"0000875320-25-000222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000222","line_url":"/filing/0000875320-25-000222#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":266.0,"shares_display":"266","price_per_share":386.69,"price_display":"386.69","price_state":"stated","total_value":102859.54,"total_display":"102,859.54","shares_owned_after":4565.0,"shares_owned_after_display":"4,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-29","scope":"insider"},{"id":4090302,"accession":"0000875320-25-000173","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000173","line_url":"/filing/0000875320-25-000173#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":505.86,"price_display":"505.86","price_state":"stated","total_value":202344.0,"total_display":"202,344.00","shares_owned_after":4831.0,"shares_owned_after_display":"4,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-05","scope":"insider"},{"id":2106412,"accession":"0000875320-24-000211","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000211","line_url":"/filing/0000875320-24-000211#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":646.0,"shares_display":"646","price_per_share":500.0,"price_display":"500.00","price_state":"stated","total_value":323000.0,"total_display":"323,000.00","shares_owned_after":4435.0,"shares_owned_after_display":"4,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-30","filed_date":"2024-09-04","scope":"insider"},{"id":2034985,"accession":"0000875320-24-000204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000204","line_url":"/filing/0000875320-24-000204#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1292.0,"shares_display":"1,292","price_per_share":466.29,"price_display":"466.29","price_state":"stated","total_value":602446.68,"total_display":"602,446.68","shares_owned_after":4435.0,"shares_owned_after_display":"4,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-08","filed_date":"2024-08-12","scope":"insider"},{"id":2411971,"accession":"0000875320-24-000117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000117","line_url":"/filing/0000875320-24-000117#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":467.0,"shares_display":"467","price_per_share":402.95,"price_display":"402.95","price_state":"stated","total_value":188177.65,"total_display":"188,177.65","shares_owned_after":4435.0,"shares_owned_after_display":"4,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":8609374,"accession":"0001209191-23-053175","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053175","line_url":"/filing/0001209191-23-053175#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243.0,"shares_display":"243","price_per_share":375.0,"price_display":"375.00","price_state":"stated","total_value":91125.0,"total_display":"91,125.00","shares_owned_after":3901.0,"shares_owned_after_display":"3,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-17","filed_date":"2023-10-19","scope":"insider"},{"id":8704682,"accession":"0001209191-23-052622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052622","line_url":"/filing/0001209191-23-052622#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":242.0,"shares_display":"242","price_per_share":360.0,"price_display":"360.00","price_state":"stated","total_value":87120.0,"total_display":"87,120.00","shares_owned_after":4144.0,"shares_owned_after_display":"4,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-06","filed_date":"2023-10-11","scope":"insider"},{"id":7887045,"accession":"0000899243-23-018043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-018043","line_url":"/filing/0000899243-23-018043#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":242.0,"shares_display":"242","price_per_share":345.51,"price_display":"345.51","price_state":"stated","total_value":83613.42,"total_display":"83,613.42","shares_owned_after":4386.0,"shares_owned_after_display":"4,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-11","scope":"insider"},{"id":7814820,"accession":"0001209191-23-026991","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-026991","line_url":"/filing/0001209191-23-026991#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":172.0,"shares_display":"172","price_per_share":346.69,"price_display":"346.69","price_state":"stated","total_value":59630.68,"total_display":"59,630.68","shares_owned_after":4974.0,"shares_owned_after_display":"4,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-03","scope":"insider"},{"id":7814817,"accession":"0001209191-23-026991","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-026991","line_url":"/filing/0001209191-23-026991#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":163.0,"shares_display":"163","price_per_share":349.82,"price_display":"349.82","price_state":"stated","total_value":57020.66,"total_display":"57,020.66","shares_owned_after":4691.0,"shares_owned_after_display":"4,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-03","scope":"insider"},{"id":7814814,"accession":"0001209191-23-026991","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-026991","line_url":"/filing/0001209191-23-026991#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120.0,"shares_display":"120","price_per_share":348.16,"price_display":"348.16","price_state":"stated","total_value":41779.2,"total_display":"41,779.20","shares_owned_after":4854.0,"shares_owned_after_display":"4,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-03","scope":"insider"},{"id":7814811,"accession":"0001209191-23-026991","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-026991","line_url":"/filing/0001209191-23-026991#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63.0,"shares_display":"63","price_per_share":351.2,"price_display":"351.20","price_state":"stated","total_value":22125.6,"total_display":"22,125.60","shares_owned_after":4628.0,"shares_owned_after_display":"4,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-03","scope":"insider"},{"id":7814809,"accession":"0001209191-23-026991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-026991","line_url":"/filing/0001209191-23-026991#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62.0,"shares_display":"62","price_per_share":345.93,"price_display":"345.93","price_state":"stated","total_value":21447.66,"total_display":"21,447.66","shares_owned_after":5146.0,"shares_owned_after_display":"5,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-03","scope":"insider"},{"id":6945325,"accession":"0000899243-22-034249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034249","line_url":"/filing/0000899243-22-034249#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":621.0,"shares_display":"621","price_per_share":310.0,"price_display":"310.00","price_state":"stated","total_value":192510.0,"total_display":"192,510.00","shares_owned_after":4040.0,"shares_owned_after_display":"4,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-26","scope":"insider"},{"id":6386333,"accession":"0000899243-22-028250","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-028250","line_url":"/filing/0000899243-22-028250#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":204.0,"shares_display":"204","price_per_share":293.15,"price_display":"293.15","price_state":"stated","total_value":59802.6,"total_display":"59,802.60","shares_owned_after":4869.0,"shares_owned_after_display":"4,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6386331,"accession":"0000899243-22-028250","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-028250","line_url":"/filing/0000899243-22-028250#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":164.0,"shares_display":"164","price_per_share":291.76,"price_display":"291.76","price_state":"stated","total_value":47848.64,"total_display":"47,848.64","shares_owned_after":5073.0,"shares_owned_after_display":"5,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6386328,"accession":"0000899243-22-028250","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-028250","line_url":"/filing/0000899243-22-028250#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161.0,"shares_display":"161","price_per_share":294.24,"price_display":"294.24","price_state":"stated","total_value":47372.64,"total_display":"47,372.64","shares_owned_after":4708.0,"shares_owned_after_display":"4,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6386326,"accession":"0000899243-22-028250","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-028250","line_url":"/filing/0000899243-22-028250#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47.0,"shares_display":"47","price_per_share":295.53,"price_display":"295.53","price_state":"stated","total_value":13889.91,"total_display":"13,889.91","shares_owned_after":4661.0,"shares_owned_after_display":"4,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6386323,"accession":"0000899243-22-028250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-028250","line_url":"/filing/0000899243-22-028250#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45.0,"shares_display":"45","price_per_share":290.18,"price_display":"290.18","price_state":"stated","total_value":13058.1,"total_display":"13,058.10","shares_owned_after":5237.0,"shares_owned_after_display":"5,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-10","scope":"insider"},{"id":6167280,"accession":"0000899243-22-027386","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-027386","line_url":"/filing/0000899243-22-027386#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":277.95,"price_display":"277.95","price_state":"stated","total_value":55590.0,"total_display":"55,590.00","shares_owned_after":5604.0,"shares_owned_after_display":"5,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-02","scope":"insider"},{"id":6167273,"accession":"0000899243-22-027386","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-027386","line_url":"/filing/0000899243-22-027386#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160.0,"shares_display":"160","price_per_share":279.28,"price_display":"279.28","price_state":"stated","total_value":44684.8,"total_display":"44,684.80","shares_owned_after":5444.0,"shares_owned_after_display":"5,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-02","scope":"insider"},{"id":6167270,"accession":"0000899243-22-027386","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-027386","line_url":"/filing/0000899243-22-027386#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99.0,"shares_display":"99","price_per_share":280.22,"price_display":"280.22","price_state":"stated","total_value":27741.78,"total_display":"27,741.78","shares_owned_after":5345.0,"shares_owned_after_display":"5,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-02","scope":"insider"},{"id":6167268,"accession":"0000899243-22-027386","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-027386","line_url":"/filing/0000899243-22-027386#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99.0,"shares_display":"99","price_per_share":276.65,"price_display":"276.65","price_state":"stated","total_value":27388.35,"total_display":"27,388.35","shares_owned_after":5804.0,"shares_owned_after_display":"5,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-02","scope":"insider"},{"id":6167266,"accession":"0000899243-22-027386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-027386","line_url":"/filing/0000899243-22-027386#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58.0,"shares_display":"58","price_per_share":281.03,"price_display":"281.03","price_state":"stated","total_value":16299.74,"total_display":"16,299.74","shares_owned_after":5287.0,"shares_owned_after_display":"5,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-02","scope":"insider"},{"id":6167264,"accession":"0000899243-22-027386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-027386","line_url":"/filing/0000899243-22-027386#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5.0,"shares_display":"5","price_per_share":282.34,"price_display":"282.34","price_state":"stated","total_value":1411.7,"total_display":"1,411.70","shares_owned_after":5282.0,"shares_owned_after_display":"5,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-02","scope":"insider"},{"id":6767456,"accession":"0000899243-22-016638","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-22-016638","line_url":"/filing/0000899243-22-016638#line-7","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280.0,"shares_display":"280","price_per_share":257.51,"price_display":"257.51","price_state":"stated","total_value":72102.8,"total_display":"72,102.80","shares_owned_after":6320.0,"shares_owned_after_display":"6,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6767455,"accession":"0000899243-22-016638","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-016638","line_url":"/filing/0000899243-22-016638#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120.0,"shares_display":"120","price_per_share":259.75,"price_display":"259.75","price_state":"stated","total_value":31170.0,"total_display":"31,170.00","shares_owned_after":6080.0,"shares_owned_after_display":"6,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6767451,"accession":"0000899243-22-016638","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-016638","line_url":"/filing/0000899243-22-016638#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120.0,"shares_display":"120","price_per_share":258.9,"price_display":"258.90","price_state":"stated","total_value":31068.0,"total_display":"31,068.00","shares_owned_after":6200.0,"shares_owned_after_display":"6,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6767449,"accession":"0000899243-22-016638","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-016638","line_url":"/filing/0000899243-22-016638#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91.0,"shares_display":"91","price_per_share":261.91,"price_display":"261.91","price_state":"stated","total_value":23833.81,"total_display":"23,833.81","shares_owned_after":5909.0,"shares_owned_after_display":"5,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6767447,"accession":"0000899243-22-016638","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-016638","line_url":"/filing/0000899243-22-016638#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80.0,"shares_display":"80","price_per_share":260.82,"price_display":"260.82","price_state":"stated","total_value":20865.6,"total_display":"20,865.60","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6767445,"accession":"0000899243-22-016638","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-016638","line_url":"/filing/0000899243-22-016638#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40.0,"shares_display":"40","price_per_share":255.4,"price_display":"255.40","price_state":"stated","total_value":10216.0,"total_display":"10,216.00","shares_owned_after":6600.0,"shares_owned_after_display":"6,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6767443,"accession":"0000899243-22-016638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-016638","line_url":"/filing/0000899243-22-016638#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6.0,"shares_display":"6","price_per_share":264.37,"price_display":"264.37","price_state":"stated","total_value":1586.22,"total_display":"1,586.22","shares_owned_after":5903.0,"shares_owned_after_display":"5,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6803316,"accession":"0000899243-22-014549","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-014549","line_url":"/filing/0000899243-22-014549#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1907.0,"shares_display":"1,907","price_per_share":280.2,"price_display":"280.20","price_state":"stated","total_value":534341.4,"total_display":"534,341.40","shares_owned_after":5191.0,"shares_owned_after_display":"5,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-12","scope":"insider"},{"id":4274185,"accession":"0001209191-21-038182","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-038182","line_url":"/filing/0001209191-21-038182#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":285.0,"shares_display":"285","price_per_share":208.96,"price_display":"208.96","price_state":"stated","total_value":59553.6,"total_display":"59,553.60","shares_owned_after":5465.0,"shares_owned_after_display":"5,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"},{"id":4274181,"accession":"0001209191-21-038182","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-038182","line_url":"/filing/0001209191-21-038182#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153.0,"shares_display":"153","price_per_share":210.01,"price_display":"210.01","price_state":"stated","total_value":32131.53,"total_display":"32,131.53","shares_owned_after":5312.0,"shares_owned_after_display":"5,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"},{"id":4274176,"accession":"0001209191-21-038182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-038182","line_url":"/filing/0001209191-21-038182#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":121.0,"shares_display":"121","price_per_share":211.0,"price_display":"211.00","price_state":"stated","total_value":25531.0,"total_display":"25,531.00","shares_owned_after":5191.0,"shares_owned_after_display":"5,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"},{"id":2294491,"accession":"0001209191-20-054118","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-054118","line_url":"/filing/0001209191-20-054118#line-8","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2670.0,"shares_display":"2,670","price_per_share":267.92,"price_display":"267.92","price_state":"stated","total_value":715346.4,"total_display":"715,346.40","shares_owned_after":6120.0,"shares_owned_after_display":"6,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-07","scope":"insider"},{"id":2294489,"accession":"0001209191-20-054118","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-054118","line_url":"/filing/0001209191-20-054118#line-7","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2212.0,"shares_display":"2,212","price_per_share":268.61,"price_display":"268.61","price_state":"stated","total_value":594165.32,"total_display":"594,165.32","shares_owned_after":3908.0,"shares_owned_after_display":"3,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-07","scope":"insider"},{"id":2294486,"accession":"0001209191-20-054118","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-054118","line_url":"/filing/0001209191-20-054118#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2070.0,"shares_display":"2,070","price_per_share":266.66,"price_display":"266.66","price_state":"stated","total_value":551986.2,"total_display":"551,986.20","shares_owned_after":8790.0,"shares_owned_after_display":"8,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-07","scope":"insider"},{"id":2294482,"accession":"0001209191-20-054118","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-054118","line_url":"/filing/0001209191-20-054118#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1787.0,"shares_display":"1,787","price_per_share":265.82,"price_display":"265.82","price_state":"stated","total_value":475020.34,"total_display":"475,020.34","shares_owned_after":10860.0,"shares_owned_after_display":"10,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-07","scope":"insider"},{"id":2294478,"accession":"0001209191-20-054118","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-054118","line_url":"/filing/0001209191-20-054118#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":892.0,"shares_display":"892","price_per_share":264.6,"price_display":"264.60","price_state":"stated","total_value":236023.2,"total_display":"236,023.20","shares_owned_after":12647.0,"shares_owned_after_display":"12,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-07","scope":"insider"},{"id":2294473,"accession":"0001209191-20-054118","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-054118","line_url":"/filing/0001209191-20-054118#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":594.0,"shares_display":"594","price_per_share":263.54,"price_display":"263.54","price_state":"stated","total_value":156542.76,"total_display":"156,542.76","shares_owned_after":13539.0,"shares_owned_after_display":"13,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-07","scope":"insider"},{"id":2294468,"accession":"0001209191-20-054118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-054118","line_url":"/filing/0001209191-20-054118#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":291.0,"shares_display":"291","price_per_share":262.66,"price_display":"262.66","price_state":"stated","total_value":76434.06,"total_display":"76,434.06","shares_owned_after":14133.0,"shares_owned_after_display":"14,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-07","scope":"insider"},{"id":3313127,"accession":"0001209191-20-033993","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-033993","line_url":"/filing/0001209191-20-033993#line-7","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":313.0,"shares_display":"313","price_per_share":282.86,"price_display":"282.86","price_state":"stated","total_value":88535.18,"total_display":"88,535.18","shares_owned_after":6084.0,"shares_owned_after_display":"6,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-03","scope":"insider"},{"id":3313122,"accession":"0001209191-20-033993","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-033993","line_url":"/filing/0001209191-20-033993#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":289.0,"shares_display":"289","price_per_share":283.84,"price_display":"283.84","price_state":"stated","total_value":82029.76,"total_display":"82,029.76","shares_owned_after":5795.0,"shares_owned_after_display":"5,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-03","scope":"insider"},{"id":3313119,"accession":"0001209191-20-033993","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-033993","line_url":"/filing/0001209191-20-033993#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":281.2,"price_display":"281.20","price_state":"stated","total_value":56240.0,"total_display":"56,240.00","shares_owned_after":6397.0,"shares_owned_after_display":"6,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-03","scope":"insider"},{"id":3313116,"accession":"0001209191-20-033993","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-033993","line_url":"/filing/0001209191-20-033993#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":285.73,"price_display":"285.73","price_state":"stated","total_value":14286.5,"total_display":"14,286.50","shares_owned_after":5695.0,"shares_owned_after_display":"5,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-03","scope":"insider"},{"id":3313111,"accession":"0001209191-20-033993","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-033993","line_url":"/filing/0001209191-20-033993#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001643921","owner_name":"Bhatia Sangeeta N.","owner_url":"/insider/0001643921","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":284.62,"price_display":"284.62","price_state":"stated","total_value":14231.0,"total_display":"14,231.00","shares_owned_after":5745.0,"shares_owned_after_display":"5,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-03","scope":"insider"}],"next_cursor":"2020-06-02|3313111","ledger_fault":false,"count":{"value":63,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":63,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":63},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Director","n_filings":27,"first_seen":"2017-06-05","last_seen":"2026-05-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001643921","retrieved_at":"2026-08-21T03:54:52+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}